Black Diamond Therapeutics
BDTX
BDTX
109 hedge funds and large institutions have $915M invested in Black Diamond Therapeutics in 2020 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 43 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
13.2% more ownership
Funds ownership: 66.17% → 79.37% (+13%)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
109
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$19.4M | |
| 2 | +$18.5M | |
| 3 | +$17.4M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$10.5M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.46M |
Top Sellers
| 1 | -$4.4M | |
| 2 | -$2.08M | |
| 3 | -$1.27M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$817K |
| 5 |
TC
Telemus Capital
Southfield,
Michigan
|
-$506K |